Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of FOXP2 mRNA | affects expression | 20382639
|
D003024 |
Clozapine |
Clozapine results in increased expression of FOXP2 mRNA | increases expression | 17266109
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of FOXP2 mRNA | affects cotreatment|decreases expression | 17183730
|
D008345 |
Manganese |
Manganese results in increased expression of FOXP2 mRNA | increases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in increased expression of FOXP2 mRNA | increases expression | 17175027
|
D010622 |
Phencyclidine |
Phencyclidine results in increased expression of FOXP2 mRNA | increases expression | 17266109
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of FOXP2 mRNA | increases expression | 18301758
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of FOXP2 mRNA | affects cotreatment|decreases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.82 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.82 | 16434500 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.36 | 12649775 16160616 14617031 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
11.85 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
11.85 | 16910769 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
MESH:D001072 |
Apraxias |
marker/mechanism |
|
| 17033973 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15108192 17033973 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 20603192 17688650 17507914 17157402 15238991 19232924 18316065 19460635 18940202 18396377 18558336 18177632 16609825 18775368 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.39 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.54 | 8888407 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.88 | 20889678 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.00 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.27 | 17123785 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 17033973 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 8888407 16575769 17688650 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
3.02 | 16402076 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.93 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.23 | 1733752 19641884 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.35 | 16402076 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.72 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.12 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.54 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.54 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 8888407 18558336 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
4.06 | 17043766 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.30 | 19176532 18467677 19772884 16221962 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.25 | 16046005 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.93 | 16612254 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 16294345 17596541 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.13 | 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.89 | 20007298 16377806 15890375 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
5.90 | 19453300 16551646 16568477 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
4.28 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.61 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18803445 18765137 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
5.27 | 16551646 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.28 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.05 | 17405874 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.46 | 16551646 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.27 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.87 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.87 | 20558911 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.44 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.70 | 16140633 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.17 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 12752131 11422049 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.35 | 15331141 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.44 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
3.92 | 17667964 17123785 20168265 19369910 11763009 20521320 20452607 11151749 20580759 18806925 18855531 16141801 20107430 17726453 20521326 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
3.92 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.89 | 1511512 11738929 14763951 16876388 11044598 15475178 17978042 3137016 |
MESH:D056730 |
Silver-Russell Syndrome |
marker/mechanism |
|
| 17033973 |
OMIM:602081 |
SPEECH-LANGUAGE DISORDER 1 |
marker/mechanism |
|
| |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.68 | 20564506 20521320 16141801 20107430 16402076 17502770 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.41 | 17933447 |